Please Wait.....
Report
NA Hereditary Cancer Testing Market - Industry Trends and Forecast to 2029
Market Report I 2022-10-01 I 149 Pages I Data Bridge Market Research
North America hereditary cancer testing market is projected to register a CAGR of 13.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Market Segmentation:
North America Hereditary Cancer Testing Market, By Test Type (Multi Panel Set, and Single-Site Genetic Test) Diagnosis Type (Biopsy, Imaging, Lab Tests) Technology (Sequencing, Polymerase Chain Reaction (PCR), Microarray) Disease Type (Hereditary Breast & Ovarian Cancer Syndrome, Cowden Syndrome, Lynch Syndrome, Hereditary Leukemia And Hematologic Malignancies Syndromes, Familial Adenomatous Polyposis (FAP), Li-Fraumeni Syndrome, Vol-Hippel Lindau Disease, Multiple Endocrine Neoplasias (MEN) Syndromes) End User (Hospitals, Clinics, Laboratories, Radiology Centers, Diagnostic Centers, Others) Distribution Channel (Direct Tender, Retail Sales) Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029
Some of the factors boosting the growth of the hereditary cancer testing market are:
- Rising incidence of hereditary cancer
- Increased demand for non-invasive testing methods
Market Players:
The key market players for North America hereditary cancer testing market are listed below:
- Invitae Corporation
- Illumina, Inc.
- Natera, Inc.
- CENTOGENE N.V.
- 4baseCare
- Biocartis
- Fulgent Genetics
- Ambry Genetics
- BioReference
- PerkinElmer Inc.
- LifeLabs
- Abbott
- BIO-HELIX
- Cepheid
- Eurofins Scientific
TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE NORTH AMERICA HEREDITARY CANCER TESTING MARKET 14
1.4 CURRENCY AND PRICING 16
1.5 LIMITATIONS 16
1.6 MARKETS COVERED 17
2 MARKET SEGMENTATION 20
2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 22
2.4 DBMR TRIPOD DATA VALIDATION MODEL 23
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
2.6 MULTIVARIATE MODELLING 27
2.7 MARKET END USER COVERAGE GRID 28
2.8 SOURCE LIFELINE CURVE 29
2.9 DBMR MARKET POSITION GRID 30
2.10 VENDOR SHARE ANALYSIS 32
2.11 SECONDARY SOURCES 33
2.12 ASSUMPTIONS 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHT 37
4.1 PESTEL ANALYSIS 38
4.2 PORTER'S FIVE FORCES 39
5 NORTH AMERICA HEREDITARY CANCER TESTING MARKET: REGULATIONS 40
6 MARKET OVERVIEW 45
6.1 DRIVERS 47
6.1.1 RISING INCIDENCE OF HEREDITARY CANCER 47
6.1.2 INCREASE IN THE GERIATRIC POPULATION 47
6.1.3 RISING HEALTHCARE SPENDING 48
6.1.4 INCREASE IN AWARENESS ABOUT CANCER TESTING 48
6.2 RESTRAINTS 49
6.2.1 HIGH COST OF HEREDITARY CANCER TESTING 49
6.2.2 LACK OF SKILLED PROFESSIONALS 50
6.3 OPPORTUNITIES 50
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 50
6.3.2 INCREASED DEMAND FOR NON-INVASIVE TESTING METHODS 51
6.3.3 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS 52
6.3.4 TECHNOLOGICAL DEVELOPMENTS IN HEREDITARY CANCER TESTING PROCEDURES 52
6.4 CHALLENGES 53
6.4.1 ETHICAL CHALLENGES FACED DURING HEREDITARY CANCER TESTING 53
6.4.2 RISING COMPETITION AMONG MARKET PLAYERS 54
7 NORTH AMERICA HEREDITARY CANCER TESTING MARKET, BY TEST TYPE 55
7.1 OVERVIEW 56
7.2 MULTI PANEL TEST 59
7.3 SINGLE-SITE GENETIC TEST 59
8 NORTH AMERICA HEREDITARY CANCER TESTING MARKET, BY DIAGNOSIS TYPE 60
8.1 OVERVIEW 61
8.2 BIOPSY 64
8.2.1 NEEDLE BIOPSIES 64
8.2.2 ENDOSCOPIC BIOPSIES 64
8.2.3 LAPAROSCOPIC, THORACOSCOPIC, AND MEDIASTINOSCOPIC BIOPSY 65
8.2.4 LAPAROTOMY AND THORACOTOMY 65
8.2.5 OTHERS 65
8.3 IMAGING 65
8.3.1 MAGNETIC RESONANCE IMAGING (MRI) 66
8.3.2 COMPUTED TOMOGRAPHY (CT) SCAN 66
8.3.3 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 66
8.3.4 NUCLEAR SCAN 66
8.3.5 ULTRASOUND 66
8.3.6 X-RAYS 66
8.4 LAB TESTS 67
8.4.1 BLOOD 67
8.4.2 URINE 67
8.4.3 OTHERS 67
9 NORTH AMERICA HEREDITARY CANCER TESTING MARKET, BY TECHNOLOGY 68
9.1 OVERVIEW 69
9.2 POLYMERASE CHAIN REACTION (PCR) 72
9.3 SEQUENCING 72
9.4 MICRO ARRAY 73
10 NORTH AMERICA HEREDITARY CANCER TESTING MARKET, BY DISEASE TYPE 74
10.1 OVERVIEW 75
10.2 HEREDITARY BREAST & OVARIAN CANCER SYNDROME 78
10.3 COWDEN SYNDROME 78
10.4 LYNCH SYNDROME 79
10.5 HEREDITARY LEUKEMIA AND HEMATOLOGIC MALIGNANCIES SYNDROME 79
10.6 FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 80
10.7 LI-FRAUMENI SYNDROME 80
10.8 VON HIPPEL-LINDAU DISEASE 81
10.9 MULTIPLE ENDOCRINE NEOPLASIAS (MEN) SYNDROME 81
11 NORTH AMERICA HEREDITARY CANCER TESTING MARKET, BY END USER 82
11.1 OVERVIEW 83
11.2 HOSPITALS 86
11.3 CLINICS 86
11.4 DIAGNOSTIC CENTERS 87
11.5 RADIOLOGY CENTERS 87
11.6 LABORATORIES 88
11.7 OTHERS 88
12 NORTH AMERICA HEREDITARY CANCER TESTING MARKET, BY DISTRIBUTION CHANNEL 89
12.1 OVERVIEW 90
12.2 DIRECT TENDER 93
12.3 RETAIL SALES 93
13 NORTH AMERICA HEREDITARY CANCER TESTING MARKET, BY REGION 94
13.1 NORTH AMERICA 95
13.1.1 U.S. 102
13.1.2 CANADA 106
13.1.3 MEXICO 110
14 NORTH AMERICA HEREDITARY CANCER TESTING MARKET: COMPANY LANDSCAPE 114
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 114
15 SWOT ANALYSIS 115
16 COMPANY PROFILE 116
16.1 ABBOTT 116
16.1.1 COMPANY SNAPSHOT 116
16.1.2 REVENUE ANALYSIS 116
16.1.3 COMPANY SHARE ANALYSIS 117
16.1.4 PRODUCT PORTFOLIO 117
16.1.5 RECENT DEVELOPMENTS 117
16.2 ILLUMINA, INC. (2021) 118
16.2.1 COMPANY SNAPSHOT 118
16.2.2 REVENUE ANALYSIS 118
16.2.3 COMPANY SHARE ANALYSIS 119
16.2.4 PRODUCT PORTFOLIO 119
16.2.5 RECENT DEVELOPMENTS 120
16.3 PERKINELMER INC. (2021) 121
16.3.1 COMPANY SNAPSHOT 121
16.3.2 REVENUE ANALYSIS 121
16.3.3 COMPANY SHARE ANALYSIS 122
16.3.4 PRODUCT PORTFOLIO 122
16.3.5 RECENT DEVELOPMENTS 122
16.4 LIFELABS GENETICS 123
16.4.1 COMPANY SNAPSHOT 123
16.4.2 COMPANY SHARE ANALYSIS 123
16.4.3 PRODUCT PORTFOLIO 124
16.4.4 RECENT DEVELOPMENTS 124
16.5 EUROFINS SCIENTIFIC (2021) 125
16.5.1 COMPANY SNAPSHOT 125
16.5.2 REVENUE ANALYSIS 125
16.5.3 COMPANY SHARE ANALYSIS 126
16.5.4 PRODUCT PORTFOLIO 126
16.5.5 RECENT DEVELOPMENT 126
16.6 AMBRY GENETICS 127
16.6.1 COMPANY SNAPSHOT 127
16.6.2 REVENUE ANALYSIS 127
16.6.3 PRODUCT PORTFOLIO 128
16.6.4 RECENT DEVELOPMENTS 128
16.7 BIOCARTIS 129
16.7.1 COMPANY SNAPSHOT 129
16.7.2 REVENUE ANALYSIS 129
16.7.3 PRODUCT PORTFOLIO 130
16.7.4 RECENT DEVELOPMENTS 130
16.8 BIO-HELIX 131
16.8.1 COMPANY SNAPSHOT 131
16.8.2 PRODUCT PORTFOLIO 131
16.8.3 RECENT DEVELOPMENTS 131
16.9 BIOREFERENCE (A SUBSIDIARY OF OPKO HEALTH, INC.) (2021) 132
16.9.1 COMPANY SNAPSHOT 132
16.9.2 REVENUE ANALYSIS 132
16.9.3 PRODUCT PORTFOLIO 133
16.9.4 RECENT DEVELOPMENT 133
16.10 CENTOGENE N.V. (2021) 134
16.10.1 COMPANY SNAPSHOT 134
16.10.2 REVENUE ANALYSIS 134
16.10.3 PRODUCT PORTFOLIO 135
16.10.4 RECENT DEVELOPMENT 135
16.11 CEPHEID 136
16.11.1 COMPANY SNAPSHOT 136
16.11.2 PRODUCT PORTFOLIO 136
16.11.3 RECENT DEVELOPMENT 136
16.12 FULGENT GENETICS 137
16.12.1 COMPANY SNAPSHOT 137
16.12.2 REVENUE ANALYSIS 137
16.12.3 PRODUCT PORTFOLIO 138
16.12.4 RECENT DEVELOPMENT 138
16.13 INVITAE CORPORATION 139
16.13.1 COMPANY SNAPSHOT 139
16.13.2 REVENUE ANALYSIS 139
16.13.3 PRODUCT PORTFOLIO 140
16.13.4 RECENT DEVELOPMENT 140
16.14 NATERA, INC. (2021) 141
16.14.1 COMPANY SNAPSHOT 141
16.14.2 REVENUE ANALYSIS 141
16.14.3 PRODUCT PORTFOLIO 142
16.14.4 RECENT DEVELOPMENTS 142
16.15 4BASECARE. 144
16.15.1 COMPANY SNAPSHOT 144
16.15.2 PRODUCT PORTFOLIO 144
16.15.3 RECENT DEVELOPMENTS 145
17 QUESTIONNAIRE 146
18 RELATED REPORTS 149
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security